Clinical Trials Browser

Phase 1 × Infections × 90 days × Clear all

NCT07614282 2026-05-29

Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia

Phase 1 Not yet recruiting

Infections, Epstein-Barr Virus Infections